Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Andrea Reis Bernardes-EngemannFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Micologia, Rio de Janeiro 21040-900, RJ, Brazil.
Fernando Almeida-SilvaFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Micologia, Rio de Janeiro 21040-900, RJ, Brazil.ORCID 0000-0002-7378-1990
Levi G CleareAlbert Einstein College of Medicine, Departments of Medicine (Division of Infectious Diseases) & Microbiology & Immunology, Bronx, NY 10461, USA.
Jefferson D da CruzFundação Oswaldo Cruz, Instituto de Tecnologia em Fármacos (Farmanguinhos), Laboratório de Química de Produtos Naturais, Rio de Janeiro 21040-900, RJ, Brazil.ORCID 0000-0002-0403-3198
Jefferson Rocha de A SilvaUniversidade Federal do Amazonas, Instituto de Ciências Exatas, Departamento de Química, Laboratório de Cromatografia, Manaus 69077-000, AM, Brazil.
Walter Sotto M Fernandes NetoUniversidade Federal do Amazonas, Instituto de Ciências Exatas, Departamento de Química, Laboratório de Cromatografia, Manaus 69077-000, AM, Brazil.
Rosely Maria Zancopé-OliveiraFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Micologia, Rio de Janeiro 21040-900, RJ, Brazil.
Ana Claudia Fernandes AmaralFundação Oswaldo Cruz, Instituto de Tecnologia em Fármacos (Farmanguinhos), Laboratório de Química de Produtos Naturais, Rio de Janeiro 21040-900, RJ, Brazil.
Joshua D NosanchukAlbert Einstein College of Medicine, Departments of Medicine (Division of Infectious Diseases) & Microbiology & Immunology, Bronx, NY 10461, USA.ORCID 0000-0001-9905-5754
Rodrigo Almeida-PaesFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Micologia, Rio de Janeiro 21040-900, RJ, Brazil.ORCID 0000-0002-6639-6058
Funding
Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/201.441/2021, E-26/205.879/2022, E-26/200.381/2023National Council for Scientific and Technological Development 308315/2021-9NIH HHS NIH AI71093, NIH AI124797, and NIH AI165204
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
In Vitro Evidence for the Efficacy of Manuka Honey and Its Components Against the Major Human Pathogenic · full record | OpenQuestion